Shum Steve 4
4 · INVO Bioscience, Inc. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Shum Steve
DirectorChief Executive Officer
Transactions
- Award
Stock Option
2022-01-15+57,018→ 57,018 totalExercise: $3.61Exp: 2032-01-14→ Common Stock (57,018 underlying) - Award
Common Stock
2022-01-15+20,111→ 82,035 total
Footnotes (1)
- [F1]The stock option vests in monthly increments over a period of three years from the date of grant.